Adverse events168

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 168

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal pain	Gastrointestinal disorders	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	0	29
other	Abdominal pain	Gastrointestinal disorders	Gemcitabine Hydrochloride Plus Placebo	1	25
other	Abdominal pain	Gastrointestinal disorders	Crossover From Gemcitabine Plus Placebo to Gemcitabine Plus Open-label Pazopanib	2	14
other	Alanine aminotransferase increased	Investigations	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	3	29
other	Alanine aminotransferase increased	Investigations	Gemcitabine Hydrochloride Plus Placebo	1	25
other	Alanine aminotransferase increased	Investigations	Crossover From Gemcitabine Plus Placebo to Gemcitabine Plus Open-label Pazopanib	0	14
other	Anemia	Blood and lymphatic system disorders	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	2	29
other	Anemia	Blood and lymphatic system disorders	Gemcitabine Hydrochloride Plus Placebo	3	25
other	Anemia	Blood and lymphatic system disorders	Crossover From Gemcitabine Plus Placebo to Gemcitabine Plus Open-label Pazopanib	0	14
other	Aspartate aminotransferase increased	Investigations	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	2	29
other	Aspartate aminotransferase increased	Investigations	Gemcitabine Hydrochloride Plus Placebo	1	25
other	Aspartate aminotransferase increased	Investigations	Crossover From Gemcitabine Plus Placebo to Gemcitabine Plus Open-label Pazopanib	0	14
other	Diarrhea	Gastrointestinal disorders	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	2	29
other	Diarrhea	Gastrointestinal disorders	Gemcitabine Hydrochloride Plus Placebo	0	25
other	Diarrhea	Gastrointestinal disorders	Crossover From Gemcitabine Plus Placebo to Gemcitabine Plus Open-label Pazopanib	0	14
other	Fatigue	General disorders	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	2	29
other	Fatigue	General disorders	Gemcitabine Hydrochloride Plus Placebo	0	25
other	Fatigue	General disorders	Crossover From Gemcitabine Plus Placebo to Gemcitabine Plus Open-label Pazopanib	2	14
other	Febrile neutropenia	Blood and lymphatic system disorders	Gemcitabine Hydrochloride Plus Pazopanib Hydrochloride	2	29
other	Febrile neutropenia	Blood and lymphatic system disorders	Gemcitabine Hydrochloride Plus Placebo	2	25

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01532687/events

API reference For AI assistants

Adverse events168

Sources 3

Read this list from software.